Biolasco Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 05, 2021 at 03:40 pm
Share
BioLASCO Taiwan Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 60.313 million compared to TWD 57.970 million a year ago. Operating income was TWD 12.331 million compared to TWD 14.303 million a year ago. Net income was TWD 10.671 million compared to TWD 11.235 million a year ago. Basic earnings per share from continuing operations was TWD 0.42 compared to TWD 0.44 a year ago. For the half year, sales was TWD 109.205 million compared to TWD 149.102 million a year ago. Operating income was TWD 21.021 million compared to TWD 37.077 million a year ago. Net income was TWD 17.728 million compared to TWD 28.980 million a year ago. Basic earnings per share from continuing operations was TWD 0.69 compared to TWD 1.13 a year ago.
BioLASCO Taiwan Co., Ltd. is a Taiwan-based company mainly engaged in the production of Specific Pathogen Free (SPF) laboratory animals and the high-value special-mode experimental animals, as well as the introduction and production of highly-applicable disease-mode animals. The company also provides equipment related to feeding, supplies and testing platform, life science research and pharmaceutical development services.